IDCM2027

The BYT International Conferences on Infectious Diseases and Clinical Microbiology 2027, taking place from 21–22 July, 2027 in Bali, Indonesia, will bring together infectious disease specialists, clinical microbiologists, physicians, researchers, healthcare professionals, academics, laboratory scientists, and public health experts from around the world. The conference will provide an international platform for sharing the latest research, clinical advances, diagnostic innovations, and emerging developments in infectious diseases and clinical microbiology. Through keynote lectures, scientific sessions, oral and poster presentations, and interactive discussions, participants will have opportunities to exchange knowledge and explore effective strategies for the prevention, diagnosis, treatment, and control of infectious diseases. The conference will cover a broad range of topics, including emerging and re-emerging infectious diseases, antimicrobial resistance, clinical microbiology, microbial diagnostics, virology, bacteriology, parasitology, mycology, infection prevention and control, vaccine development, epidemiology, immunology, molecular diagnostics, and global health. The event will also encourage professional networking, research collaboration, and the exchange of innovative ideas among experts from different disciplines. Join us in Bali, Indonesia, from 21–22 July 2027 for an inspiring experience of scientific learning, collaboration, and advancing the future of infectious disease research and clinical microbiology.

Prof. Sujogya Kumar Panda has earned wide recognition for his pioneering contributions in microbiology, ethnobotany, and translational science. His accolades include the Best Senior Scientist Award (Microbiologist Society of India, 2024–25), multiple postdoctoral fellowships under RUSA 2.0 (Utkal University, 2020), Horizon 2020 (KU Leuven, 2016 & 2018), Erasmus-Mundus EMINTE (Lund University, 2014), and the Fast Track Young Scientist Award (SERB, Govt. of India, 2012). He has also served as a Visiting Scholar at KU Leuven (2022), CICOPS Visiting Professor at the University of Pavia (2016–17), and won KU Leuven’s prestigious award for the Best Exploitation Plan in Research-Technology & Knowledge Transfer (2018–19). Editorially, he contributes as Associate Editor for Frontiers in Cellular and Infection Microbiology (Biofilms), and Frontiers in Antibiotics. His publication portfolio spans elite journals, including The Lancet (10 manuscripts), Lancet Infectious Diseases, Lancet Global Health, Nature Medicine, Journal of Ethnopharmacology (7), Frontiers (>22), BMC (5), ACS Sustainable Chemistry & Engineering, and more than 30 others. He is the author of several edited volumes on natural products and infectious diseases, published by reputable publishers. Presently, he serves as the chairman of the Microbiological Society, India, and promotes the importance of biopesticides and biofertilizers. With a Scopus H-index above 40 and over 10,000 citations, Prof. Panda stands among the world’s top 2% scientists (six times consecutively, 2020-25) and the world's top 5% scientists (Global Scientist Index), reflecting his global impact in advancing microbiology, ethnopharmacology, and interdisciplinary healthcare solutions.